top of page

게시판 댓글

지노믹트리, 방광암 진단키트 ‘얼리텍B’, 식약처 혁신의료기기 지정
In News
Amster
2025년 3월 07일
Canada Immigration: A Comprehensive Guide Canada is renowned for its welcoming attitude toward immigrants, its high standard of living, and its diverse culture. With one of the most robust immigration systems in the world, Canada offers numerous pathways for individuals and families looking to settle permanently. Here's everything you need to know about immigrating to Canada.     Why Choose Canada?     Canada ranks high in global indices for quality of life, education, healthcare, and economic opportunities. The country values multiculturalism and has policies in place to support newcomers in integrating into society. Its vast landscapes and bustling cities cater to a wide variety of lifestyles, making it an ideal destination for people from all walks of life.   Major Immigration Pathways     Canada's immigration system is designed to meet the country's economic needs while promoting family reunification and humanitarian efforts. Below are the primary pathways to Canadian immigration:     1. Express Entry     The Express Entry system is a fast and efficient way for skilled workers to gain permanent residency in Canada. It manages applications for three economic immigration programs:     Federal Skilled Worker Program (FSWP)     Federal Skilled Trades Program (FSTP)     Canadian Experience Class (CEC)     For more details, visit our website: https://www.amsteroverseas.com/ #bestcanadaimmigrationconsultantsinkattappana #canadaprhelp #canadaimmigrationhelp #canadavisa #liveincanada
0
0

Amster

더보기

[종양관련유전자검사시약] 이 제품은 '의료기기'이며, '사용상의 주의사항'과 '사용방법'을 잘 읽고 사용하십시오.

logo4.png

코스닥 상장기업 (228760)

얼리텍® 대장암검사는 체외진단용 의료기기 EarlyTect Colon Cancer (제허 18-593호)를 사용하여, 사람 분변에서 추출한 DNA에서 신데칸-2(SDC2) 유전자의 메틸화(methylation)를 실시간 중합효소 연쇄반응(real-time PCR)으로 정성하여 대장암 진단에 보조적으로 사용하는 분자진단 검사입니다.

본 검사는 Han et al. Clinical Epigenetics, 2019;11:51 에 기술된 바와 같이 검사의 성능이 총 585명의 30~80세 사이 남녀를 대상으로 한 임상시험결과 대장암을 90.2%의 민감도와 특이도로 검사 결과가 갖는 임상적 의미가 일부 증명되었습니다. 그러나 본 검사는 임상적 유효성에 대한 추적관찰이 필요한 검사입니다.

대전시 유성구 테크노10로 44-6 | TEL 1522-0474 | FAX 042-861-4552 | EMAIL info@genomictree.com  COPYRIGHT © Genomictree, Inc. All rights reserved.

bottom of page